CONMED Corporation Asset Resilience Ratio
CONMED Corporation asset resilience ratio. CONMED Corporation (CNMD) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CONMED Corporation defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of CONMED Corporation (2011–2017)
Asset resilience ratio of CONMED Corporation from 2011 to 2017. This chart shows how CONMED Corporation's Asset Resilience Ratio has changed over time. Read CONMED Corporation total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down CONMED Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CNMD total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: CONMED Corporation maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
CONMED Corporation Industry Peers by Asset Resilience Ratio
Compare CONMED Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
CONMED Corporation Asset Resilience Ratio by Year (2011–2017)
CONMED Corporation asset resilience ratio by year from 2011 to 2017. The table below shows the annual Asset Resilience Ratio data for CONMED Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $1.36 Billion | -- |
| 2016-12-31 | 0.00% | $0.00 | $1.33 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $1.11 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $1.10 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $1.09 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $1.08 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $935.59 Million | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more